Research Paper Volume 14, Issue 10 pp 4586—4605
Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers
Figure 2. Validation of ioTNL in multiple datasets. (A) Boxplots of the distribution of ioTNL scores between patients with ORR and NOR in the SKCM cohort (left), the NPC cohort (middle) and the ICC cohort (right). (B) Barplots of ORR rate between ioTNL-H group and ioTNL-L group in the SKCM cohort (left), the NPC cohort (middle) and the ICC cohort (right).